Cargando…
Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study
INTRODUCTION: Most studies investigate sexual dysfunction in drug abusers; however, there are no data available about the pattern of drug abuse in patients with lifelong premature ejaculation (PE). AIM: To assess the pattern of drug abuse in patients with lifelong PE and to evaluate its potential ef...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691979/ https://www.ncbi.nlm.nih.gov/pubmed/32994156 http://dx.doi.org/10.1016/j.esxm.2020.08.008 |
_version_ | 1783614409411657728 |
---|---|
author | Mohammed, Soheir A. Abdelhamed, Amr El Sayed, Reda M. |
author_facet | Mohammed, Soheir A. Abdelhamed, Amr El Sayed, Reda M. |
author_sort | Mohammed, Soheir A. |
collection | PubMed |
description | INTRODUCTION: Most studies investigate sexual dysfunction in drug abusers; however, there are no data available about the pattern of drug abuse in patients with lifelong premature ejaculation (PE). AIM: To assess the pattern of drug abuse in patients with lifelong PE and to evaluate its potential effect on their hormonal profile. METHODS: A cross-sectional study included patients with lifelong PE (n = 76) with no prescribed medications for 1 month and age-matched control without PE (n = 48). Participants were evaluated by history, examination, Arabic index of PE, and hormonal profile. A urine sample was screened by dipstick kits for the following drug abuse tramadol, opiate, tetrahydrocannabinol (cannabis), amphetamine, barbiturate, cocaine, and benzodiazepines. Positive results were confirmed with a immunoassay drug analyzer. MAIN OUTCOME MEASURES: The outcomes of this study are positive and negative drug abuse and hormonal profile changes. RESULTS: Control patients and patients with PE showed median (interquartile range) of age 43 (33–46.8) and 38.5 (31–45) years, respectively. Drug abuse testing results showed significantly high positive drug abuse in patients with PE, 26 of 76 (34.2%), in comparison with control, 9 of 48 (19.1%) (P = .05). The most commonly abused drug was tetrahydrocannabinol in control, 3 of 9 (33.3%), and tramadol, 12 of 26 (46.2%), in patients with PE. Control patients and patients with PE with positive drug abuse had significantly higher smoking percent (P < .0001) and higher positive drug abuse history (P < .0001). However, there was no relationship between drug abuse and PE severity, and there were no significant changes in their hormonal profile. CONCLUSIONS: Drug abuse is high among patients with lifelong PE in Upper Egypt, with tramadol being the comment drug. Drug abuse is common among smokers. However, no hormonal disturbance could be shown in drug abuse patients. Drug abuse might be considered in the evaluation of patients with PE. Mohammed SA, Abdelhamed A, El Sayed RM. Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study. Sex Med 2020;8:608–614. |
format | Online Article Text |
id | pubmed-7691979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-76919792020-12-07 Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study Mohammed, Soheir A. Abdelhamed, Amr El Sayed, Reda M. Sex Med Original Research INTRODUCTION: Most studies investigate sexual dysfunction in drug abusers; however, there are no data available about the pattern of drug abuse in patients with lifelong premature ejaculation (PE). AIM: To assess the pattern of drug abuse in patients with lifelong PE and to evaluate its potential effect on their hormonal profile. METHODS: A cross-sectional study included patients with lifelong PE (n = 76) with no prescribed medications for 1 month and age-matched control without PE (n = 48). Participants were evaluated by history, examination, Arabic index of PE, and hormonal profile. A urine sample was screened by dipstick kits for the following drug abuse tramadol, opiate, tetrahydrocannabinol (cannabis), amphetamine, barbiturate, cocaine, and benzodiazepines. Positive results were confirmed with a immunoassay drug analyzer. MAIN OUTCOME MEASURES: The outcomes of this study are positive and negative drug abuse and hormonal profile changes. RESULTS: Control patients and patients with PE showed median (interquartile range) of age 43 (33–46.8) and 38.5 (31–45) years, respectively. Drug abuse testing results showed significantly high positive drug abuse in patients with PE, 26 of 76 (34.2%), in comparison with control, 9 of 48 (19.1%) (P = .05). The most commonly abused drug was tetrahydrocannabinol in control, 3 of 9 (33.3%), and tramadol, 12 of 26 (46.2%), in patients with PE. Control patients and patients with PE with positive drug abuse had significantly higher smoking percent (P < .0001) and higher positive drug abuse history (P < .0001). However, there was no relationship between drug abuse and PE severity, and there were no significant changes in their hormonal profile. CONCLUSIONS: Drug abuse is high among patients with lifelong PE in Upper Egypt, with tramadol being the comment drug. Drug abuse is common among smokers. However, no hormonal disturbance could be shown in drug abuse patients. Drug abuse might be considered in the evaluation of patients with PE. Mohammed SA, Abdelhamed A, El Sayed RM. Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study. Sex Med 2020;8:608–614. Elsevier 2020-09-29 /pmc/articles/PMC7691979/ /pubmed/32994156 http://dx.doi.org/10.1016/j.esxm.2020.08.008 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Mohammed, Soheir A. Abdelhamed, Amr El Sayed, Reda M. Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title | Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title_full | Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title_fullStr | Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title_full_unstemmed | Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title_short | Evaluation of Drug Abuse in Patients With Lifelong Premature Ejaculation: A Cross-Sectional Study |
title_sort | evaluation of drug abuse in patients with lifelong premature ejaculation: a cross-sectional study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691979/ https://www.ncbi.nlm.nih.gov/pubmed/32994156 http://dx.doi.org/10.1016/j.esxm.2020.08.008 |
work_keys_str_mv | AT mohammedsoheira evaluationofdrugabuseinpatientswithlifelongprematureejaculationacrosssectionalstudy AT abdelhamedamr evaluationofdrugabuseinpatientswithlifelongprematureejaculationacrosssectionalstudy AT elsayedredam evaluationofdrugabuseinpatientswithlifelongprematureejaculationacrosssectionalstudy |